Articles

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK;The Institute of Cancer Research, London, UK
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK;The Institute of Cancer Research, London, UK
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
The Institute of Cancer Research, London, UK
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK
The Institute of Cancer Research, London, UK
The Institute of Cancer Research, London, UK
The Institute of Cancer Research, London, UK
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Leeds Institute of Cancer and Pathology, University of Leeds, UK
Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK;The Institute of Cancer Research, London, UK
Clinical Immunology, School of Immunity and Infection, University of Birmingham, UK
Leeds Institute of Cancer and Pathology, University of Leeds, UK
Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
The Institute of Cancer Research, London, UK
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Vol. 104 No. 7 (2019): July, 2019 https://doi.org/10.3324/haematol.2018.202200